Bettina Wagenknecht

1.2k total citations
20 papers, 1.0k citations indexed

About

Bettina Wagenknecht is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bettina Wagenknecht has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Immunology. Recurrent topics in Bettina Wagenknecht's work include Cell death mechanisms and regulation (16 papers), Cancer-related Molecular Pathways (6 papers) and interferon and immune responses (4 papers). Bettina Wagenknecht is often cited by papers focused on Cell death mechanisms and regulation (16 papers), Cancer-related Molecular Pathways (6 papers) and interferon and immune responses (4 papers). Bettina Wagenknecht collaborates with scholars based in Germany, France and Switzerland. Bettina Wagenknecht's co-authors include Michael Weller, J. Dichgans, Ulrike Naumann, Wilfried Roth, Tamara Glaser, Erich Gulbins, Cornelia Grimmel, Mirjam Hermisson, Peter H. Krammer and Peter Liston and has published in prestigious journals such as The Journal of Immunology, Oncogene and FEBS Letters.

In The Last Decade

Bettina Wagenknecht

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bettina Wagenknecht Germany 18 795 270 238 184 94 20 1.0k
Beata Pyrzyńska Poland 19 608 0.8× 201 0.7× 150 0.6× 218 1.2× 81 0.9× 31 902
Eugen Ulrich United Kingdom 6 936 1.2× 340 1.3× 158 0.7× 149 0.8× 53 0.6× 7 1.2k
Raquel Parı́s Spain 8 608 0.8× 215 0.8× 101 0.4× 159 0.9× 125 1.3× 8 836
Monique Yoakim United States 10 895 1.1× 286 1.1× 232 1.0× 76 0.4× 76 0.8× 10 1.2k
Lauretta Levati Italy 20 699 0.9× 279 1.0× 134 0.6× 292 1.6× 75 0.8× 36 947
Silvia Peñuelas Spain 9 648 0.8× 443 1.6× 175 0.7× 261 1.4× 260 2.8× 9 1.0k
Jess M. Cunnick United States 19 899 1.1× 185 0.7× 330 1.4× 90 0.5× 61 0.6× 32 1.2k
Andrea Kauffmann-Zeh United Kingdom 7 1.2k 1.5× 342 1.3× 160 0.7× 203 1.1× 54 0.6× 10 1.5k
Steve A. Maxwell United States 15 606 0.8× 255 0.9× 79 0.3× 225 1.2× 58 0.6× 23 912
Sean Garrison United States 10 595 0.7× 354 1.3× 135 0.6× 142 0.8× 44 0.5× 13 970

Countries citing papers authored by Bettina Wagenknecht

Since Specialization
Citations

This map shows the geographic impact of Bettina Wagenknecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Wagenknecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Wagenknecht more than expected).

Fields of papers citing papers by Bettina Wagenknecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Wagenknecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Wagenknecht. The network helps show where Bettina Wagenknecht may publish in the future.

Co-authorship network of co-authors of Bettina Wagenknecht

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Wagenknecht. A scholar is included among the top collaborators of Bettina Wagenknecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Wagenknecht. Bettina Wagenknecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glaser, Tamara, Bettina Wagenknecht, & Michael Weller. (2001). Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Oncogene. 20(35). 4757–4767. 51 indexed citations
2.
Aulwurm, Steffen, Robert Waltereit, Ulrike Naumann, et al.. (2001). Processing of Immunosuppressive Pro-TGF-β1,2 by Human Glioblastoma Cells Involves Cytoplasmic and Secreted Furin-Like Proteases. The Journal of Immunology. 166(12). 7238–7243. 81 indexed citations
3.
Röhn, Till A., Bettina Wagenknecht, Wilfried Roth, et al.. (2001). CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release. Oncogene. 20(31). 4128–4137. 79 indexed citations
4.
Wagenknecht, Bettina, Wilfried Roth, Erich Gulbins, Hartwig Wolburg, & Michael Weller. (2001). C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis. Cell Death and Differentiation. 8(6). 595–602. 24 indexed citations
5.
Roth, Wilfried, Bettina Wagenknecht, Ulrike Naumann, et al.. (2001). APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death and Differentiation. 8(4). 403–410. 78 indexed citations
6.
Wagenknecht, Bettina, Mirjam Hermisson, Peter Groscurth, et al.. (2000). Proteasome Inhibitor‐Induced Apoptosis of Glioma Cells Involves the Processing of Multiple Caspases and Cytochrome c Release. Journal of Neurochemistry. 75(6). 2288–2297. 82 indexed citations
7.
Zipp, Frauke, Uwe Wendling, Martin K. Beyer, et al.. (2000). Dual effect of glucocorticoids on apoptosis of human autoreactive and foreign antigen-specific T cells. Journal of Neuroimmunology. 110(1-2). 214–222. 22 indexed citations
8.
Hermisson, Mirjam, Bettina Wagenknecht, Hartwig Wolburg, et al.. (2000). Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release. Oncogene. 19(19). 2338–2345. 35 indexed citations
9.
Wagenknecht, Bettina, et al.. (1999). Inhibition of drug-induced DNA fragmentation, but not cell death, of glioma cells by non-caspase protease inhibitors. Cancer Letters. 142(1). 11–16. 17 indexed citations
10.
Glaser, Tamara, Bettina Wagenknecht, Peter Groscurth, Peter H. Krammer, & Michael Weller. (1999). Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells. Oncogene. 18(36). 5044–5053. 37 indexed citations
11.
Wagenknecht, Bettina, Tamara Glaser, Ulrike Naumann, et al.. (1999). Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death and Differentiation. 6(4). 370–376. 99 indexed citations
12.
Wagenknecht, Bettina, et al.. (1999). Proteasome Inhibitors Induce p53/p21-Independent Apoptosis in Human Glioma Cells. Cellular Physiology and Biochemistry. 9(3). 117–125. 51 indexed citations
13.
Pohl, Ute, Bettina Wagenknecht, Ulrike Naumann, & Michael Weller. (1999). p53 Enhances BAK and CD95 Expression in Human Malignant Glioma Cells but Does Not Enhance CD95L-Induced Apoptosis. Cellular Physiology and Biochemistry. 9(1). 29–37. 23 indexed citations
14.
Wick, Wolfgang, Cornelia Grimmel, Bettina Wagenknecht, J. Dichgans, & Michael Weller. (1999). Betulinic Acid-Induced Apoptosis in Glioma Cells: A Sequential Requirement for New Protein Synthesis, Formation of Reactive Oxygen Species, and Caspase Processing. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1306–1312. 125 indexed citations
15.
Roth, Wilfried, Bettina Wagenknecht, Cornelia Grimmel, J. Dichgans, & Michael Weller. (1998). Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. British Journal of Cancer. 77(3). 404–411. 52 indexed citations
16.
Wagenknecht, Bettina, Jörg B. Schulz, Erich Gulbins, & Michael Weller. (1998). Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing. Cell Death and Differentiation. 5(10). 894–900. 54 indexed citations
17.
Roth, Wilfried, Bettina Wagenknecht, J. Dichgans, & Michael Weller. (1998). Interferon-α enhances CD95L-induced apoptosis of human malignant glioma cells. Journal of Neuroimmunology. 87(1-2). 121–129. 37 indexed citations
18.
Weller, Michael, Christoph Weinstock, Christine Will, et al.. (1997). CD95-Dependent T-Cell Killing by Glioma Cells Expressing CD95 Ligand: More on Tumor Immune Escape, the CD95 Counterattack, and the Immune Privilege of the Brain. Cellular Physiology and Biochemistry. 7(5). 282–288. 34 indexed citations
19.
Wagenknecht, Bettina, Martin Trepel, Andreas von Deimling, et al.. (1997). p53 Accumulation Promotes Dephosphorylation and Proteolytic Cleavage of Retinoblastoma Protein in Human Malignant Glioma Cells. Cellular Physiology and Biochemistry. 7(6). 304–311. 7 indexed citations
20.
Wagenknecht, Bettina, Erich Gulbins, Florian Läng, J. Dichgans, & Michael Weller. (1997). Lipoxygenase inhibitors block CD95 ligand‐mediated apoptosis of human malignant glioma cells. FEBS Letters. 409(1). 17–23. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beata Pyrzyńska Breakdown of academic impact, for papers by Eugen Ulrich Breakdown of academic impact, for papers by Raquel Parı́s Breakdown of academic impact, for papers by Monique Yoakim Breakdown of academic impact, for papers by Lauretta Levati Breakdown of academic impact, for papers by Silvia Peñuelas Breakdown of academic impact, for papers by Jess M. Cunnick Breakdown of academic impact, for papers by Andrea Kauffmann-Zeh Breakdown of academic impact, for papers by Steve A. Maxwell Breakdown of academic impact, for papers by Sean Garrison
Rankless by CCL
2026